Company Profile

Terrapin Pharmacy (AKA: Sequon LLC)
Profile last edited on: 7/19/2023      CAGE: 7P4L7      UEI: GAH6C8YNNEA9

Business Identifier: Improving medication adherence
Year Founded
2012
First Award
2018
Latest Award
2020
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

13 Lincoln Court
Annapolis, MD 21401
   (443) 837-0200
   N/A
   www.terrapinpharmacy.com
Location: Single
Congr. District: 03
County: Anne Arundel

Public Profile

Medherent™ is a patented remote medication management system developed by Terrapin Pharmacy personnel to tackle the problem of medication adherence. The device offers a comprehensive end-to-end solution combining Terrapin’s pharmacy fulfillment process and multi-dose packaging with an in-home dispensing device and care management software to promote adherence among complex, high-risk patients. Patients are prompted when to dispense medications from the in-home device. The system monitors when patients activate the device and alerts caregivers in real time if patients fail to dispense medications enabling prompt intervention, The system also provides access to up-to-date historical adherence data, and maintains current medication lists for patients using the device. Medherent substantially increases medication adherence rates, which helps improve clinical outcomes and patient wellbeing as well as reduce the cost of care. Who We Serve Every year, nonadherence and adverse drug effects leads to nearly 1.3 million emergency room visits in the U.S. alone. An estimated $200B is spent every year on avoidable hospitalizations due to medication noncompliance, representing roughly 10% of total healthcare expenditures.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2020 2 NIH $1,302,911
Project Title: Assessment of Medherent Medication Management Device and Adherence Platform

Key People / Management

  Shawna Allen -- Patient Care Coordinator

  Joel F Feldman

  Andrew Frisvold -- Chief Financial Officer

  Yeardley Green -- Vice President

  Susan Malerk -- Pharmacist

  Caitlin Manleigh -- Director of Agency Services

Company News

There are no news available.